Patients should not have to cross their fingers, wait, and hope for change. The hopes of hypo- and hyperthyroid patients focus on attaining individually-optimized treatment. Their hopes, wishes, and requests are not unreasonable. Effective treatment ought to alleviate symptoms and improve health outcomes. Relative changes in thyroid hormone doses have a measurable effect on certain … Continue reading 5 steps to individually-optimized thyroid therapy
This post is a brief outline of my physical "Thyroid Therapy Transformation," a glimpse into my personal life and how symptoms and body composition changed in response to changes in thyroid therapy and diet. You can see my favorite colors are pinks and blues. And it also shows many hairstyle transformations, ha ha! This post … Continue reading My body composition before and during thyroid therapy
It's April. You're a thyroid-hormone treated person with a thyroid disability on a fixed budget of thyroid hormone. Have you been feeling hypothyroid in the past few months? If so, you're not alone. If not, thank your thyroid, or your thyroid doctor. Scientific studies show a winter-season loss of Total or Free T3 (FT3) in … Continue reading Winter T3 loss: Why it matters to thyroid patients
One of Thyroid Patients Canada's values is to bring to light little-known aspects of the history of thyroid therapy so that it can open minds about future possibilities. The history of L-T3 (Liothyronine) monotherapy brings to light the flexibility and diversity of our thyroid pharmaceuticals to adapt to the unique metabolic needs of the individual. … Continue reading Finkler, 1959: Liothyronine as a replacement for thyroid therapy
As part of my post on "The thyroid gland is a T3 shield," I reviewed a research article by Ingbar and team from 1982. Wow. What a treasure. The title of this article is "Elevated serum thyroxine concentration in patients receiving 'replacement' doses of levothyroxine." Just look at that title. They began their title with … Continue reading Ingbar and Braverman’s historic study of LT4 monotherapy
